{"id":"W4253119700","doi":"10.1200/jco.2012.30.5_suppl.172","title":"A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cabazitaxel; Prednisone; Docetaxel; Prostate cancer; Cohort; Internal medicine; Interim analysis; Mitoxantrone; Abiraterone acetate; Cancer; Surgery; Oncology; Androgen deprivation therapy; Clinical trial; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001750614,0.0006779882,0.0004747511,0.0003543497,0.000483788,0.0007134693,0.0007949565,0.0005557291,0.006376265],"category_scores_gemma":[0.001516892,0.0002535825,0.001235739,0.0004915255,0.0003898671,0.0005757001,0.0007607989,0.001209269,0.001001484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00104167,"about_ca_system_score_gemma":0.0027799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003917768,"about_ca_topic_score_gemma":0.006924036,"domain_scores_codex":[0.9994864,0.0002246739,0.00001991506,0.00008455666,0.00007624312,0.0001081833],"domain_scores_gemma":[0.9983169,0.0001509207,0.0002948303,0.0002189787,0.0001004593,0.0009180332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5004003,0.07355908,0.05670477,0.0004267771,0.001864345,0.0003721781,0.0003393003,0.004277465,0.01624816,0.0003939374,0.02034654,0.3250671],"study_design_scores_gemma":[0.4401623,0.346792,0.1839868,0.00008579138,0.00157659,0.0005124682,0.0001355691,0.00405168,0.005065016,0.000459017,0.01711357,0.00005935911],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9797946,0.0009564255,0.001522921,0.0008787088,0.0001783398,0.005523362,0.006394551,0.0002325029,0.004518715],"genre_scores_gemma":[0.9650525,0.001100049,0.005724492,0.001713272,0.0003342218,0.006426738,0.01392593,0.00005617608,0.005666729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006376265,"threshold_uncertainty_score":0.02133071,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.164914439931433,"score_gpt":0.509163103084779,"score_spread":0.3442486631533459,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}